We assessed its efficacy when co-formulated with established TLR4 adjuvants and evaluated its capacity to enhance the protective immunity of TLR4-adjuvanted TB subunit vaccines against infections with Mtb clinical isolates in mice. This evidence concerns the gene TLR4 and tuberculosis.